TABLE 4.

Overall incidence of adverse events (≥2% in any group)

	Incidence, n (%)
Adverse event	Valsartan a.m. (n = 365)	Valsartan p.m. (n = 370)	Lisinopril (n = 356)
Headache	13 (3.6)	12 (3.2)	12 (3.4)
Nasopharyngitis	9 (2.5)	8 (2.2)	8 (2.2)
Bronchitis	8 (2.2)	15 (4.1)	8 (2.2)
Cough	8 (2.2)	12 (3.2)	29 (8.1)
Nausea	8 (2.2)	1 (0.3)	1 (0.3)
Vertigo	6 (1.6)	6 (1.6)	8 (2.2)
Upper abdominal pain	5 (1.4)	3 (0.8)	8 (2.2)
Diarrhoea	4 (1.1)	4 (1.1)	8 (2.2)
Back pain	3 (0.8)	9 (2.4)	6 (1.7)
Total patients with AEs	148 (40.5)	141 (38.1)	147 (41.3)

AE, adverse event.